The best described mechanism ensuring protection against fork degradation involves the BRCA proteins (comprised of the breast cancer susceptibility factors BRCA1 and BRCA2) and components of the Fanconi anemia (FA) tumor suppressor pathway, which are known effectors of homologous recombination (HR) in metazoan cells. The gene discussed is BRCA2; the disease is Friedreich ataxia.